If FBXO11 loss leads to MDS evolution through a common RNA metabolic pathway, we hypothesized that there might be an epistatic relationship between low FBXO11 expression and RNA spliceosome mutations. The gene discussed is FBXO11; the disease is myelodysplastic syndrome.